These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23425131)

  • 1. When to start ART in Africa--an urgent research priority.
    De Cock KM; El-Sadr WM
    N Engl J Med; 2013 Mar; 368(10):886-9. PubMed ID: 23425131
    [No Abstract]   [Full Text] [Related]  

  • 2. When to start antiretroviral therapy--ready when you are?
    Sax PE; Baden LR
    N Engl J Med; 2009 Apr; 360(18):1897-9. PubMed ID: 19339713
    [No Abstract]   [Full Text] [Related]  

  • 3. Should we be initiating antiretroviral therapy earlier? An argument in favour.
    Wood R
    S Afr Med J; 2005 Dec; 95(12):926, 928. PubMed ID: 16465350
    [No Abstract]   [Full Text] [Related]  

  • 4. Getting smarter--the toxicity of undertreated HIV infection.
    Currier JS; Baden LR
    N Engl J Med; 2006 Nov; 355(22):2359-61. PubMed ID: 17135590
    [No Abstract]   [Full Text] [Related]  

  • 5. Early versus deferred antiretroviral therapy for HIV.
    Hernán MA; Robins JM
    N Engl J Med; 2009 Aug; 361(8):822-3; author reply 823-4. PubMed ID: 19701984
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV survival benefit associated with earlier antiviral therapy.
    Mocroft A; Phillips AN; Lundgren JD
    Ann Intern Med; 2004 Apr; 140(7):578-9; author reply 579. PubMed ID: 15068990
    [No Abstract]   [Full Text] [Related]  

  • 7. If we can't get what we want, can we get what we need? optimizing use of antiretroviral therapy in the current era.
    Baker JV; Henry K
    Ann Intern Med; 2011 Apr; 154(8):563-5. PubMed ID: 21502654
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question.
    Eholié SP; Badje A; Kouame GM; N'takpe JB; Moh R; Danel C; Anglaret X
    AIDS Res Ther; 2016; 13():27. PubMed ID: 27462361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment. Individual approach needed for co-infections.
    AIDS Policy Law; 2011 Dec; 27(1):1. PubMed ID: 22319816
    [No Abstract]   [Full Text] [Related]  

  • 10. 2010 guidelines for antiretroviral treatment of HIV from the International AIDS Society-USA Panel.
    Bucher HC; Wolbers M; Porter K
    JAMA; 2010 Nov; 304(17):1897; author reply 1897-8. PubMed ID: 21045094
    [No Abstract]   [Full Text] [Related]  

  • 11. Early versus deferred antiretroviral therapy for HIV.
    Buchbinder SP; Jain V
    N Engl J Med; 2009 Aug; 361(8):822; author reply 823-4. PubMed ID: 19692695
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.
    Iwuji CC; Orne-Gliemann J; Tanser F; Boyer S; Lessells RJ; Lert F; Imrie J; Bärnighausen T; Rekacewicz C; Bazin B; Newell ML; Dabis F;
    Trials; 2013 Jul; 14():230. PubMed ID: 23880306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimal time for antiretroviral therapy of HIV infection: NA-ACCORD (North American AIDS cohort collaboration on research and design)].
    Jensen B; Nitschmann S; Häussinger D
    Internist (Berl); 2009 Dec; 50(12):1425-6. PubMed ID: 19902153
    [No Abstract]   [Full Text] [Related]  

  • 14. Monitoring of antiretroviral therapy in low-resource settings.
    Bendavid E
    Lancet; 2008 Jul; 372(9635):288-9; author reply 289. PubMed ID: 18657700
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality?
    Boulle A; Clayden P; Cohen K; Cohen T; Conradie F; Dong K; Geffen N; Grimwood A; Hurtado R; Kenyon C; Lawn S; Maartens G; Meintjes G; Mendelson M; Murray M; Rangaka M; Sanne I; Spencer D; Taljaard J; Variava E; Venter WD; Wilson D
    S Afr Med J; 2010 Sep; 100(9):566, 568, 570-1. PubMed ID: 20822639
    [No Abstract]   [Full Text] [Related]  

  • 16. [What happens when antiretroviral treatment is interrupted in clinical practice?].
    Marcos Sánchez F; Albo Castaño I; Joya Seijo D; del Valle Loarte P; Martín Barranco MJ
    An Med Interna; 2005 Oct; 22(10):502. PubMed ID: 16411308
    [No Abstract]   [Full Text] [Related]  

  • 17. Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.
    Babiker AG; Emery S; Fätkenheuer G; Gordin FM; Grund B; Lundgren JD; Neaton JD; Pett SL; Phillips A; Touloumi G; Vjechaj MJ;
    Clin Trials; 2013; 10(1 Suppl):S5-S36. PubMed ID: 22547421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.
    Le T; Wright EJ; Smith DM; He W; Catano G; Okulicz JF; Young JA; Clark RA; Richman DD; Little SJ; Ahuja SK
    N Engl J Med; 2013 Jan; 368(3):218-30. PubMed ID: 23323898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ending the HIV-AIDS Pandemic--Follow the Science.
    Fauci AS; Marston HD
    N Engl J Med; 2015 Dec; 373(23):2197-9. PubMed ID: 26624554
    [No Abstract]   [Full Text] [Related]  

  • 20. Co-trimoxazole, cART, and non-AIDS infectious diseases.
    Anglaret X; Eholie S
    Lancet; 2010 Apr; 375(9722):1231-3. PubMed ID: 20347482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.